Eribulin Mesylate Drug Interactions: 222 Major, 121 Moderate
Eribulin Mesylate Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Eribulin Mesylate. Always confirm against the full prescribing information.
100 interactions
Allopurinol
The risk or severity of adverse effects can be increased when Allopurinol is combined with Eribulin.
Level 1 evidence
Amiodarone
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Amiodarone.
Level 2 evidence
Anagrelide
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Anagrelide.
Level 2 evidence
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Eribulin.
Level 2 evidence
Artemether
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Artemether.
Level 2 evidence
Articaine
The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Articaine.
Level 1 evidence
Asenapine
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Asenapine.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Eribulin.
Level 2 evidence
Bedaquiline
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Bedaquiline.
Level 1 evidence
Benzocaine
The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Benzocaine.
Level 1 evidence
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Benzyl alcohol.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Eribulin.
Level 2 evidence
Enter your NPI to unlock 42 major interactions for Eribulin Mesylate
Eribulin Mesylate has 575 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Eribulin Mesylate has 222 major, 121 moderate, and 232 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Eribulin Mesylate. Always confirm against the full prescribing information.